Specialist healthcare investor, Gilde Healthcare, plans to acquire Sanquin Reagents from Sanquin Health Solutions (SHS) as the first investment from its €517m private equity fund (GHPE IV) that closed in…
Specialist healthcare investor, Gilde Healthcare, plans to acquire Sanquin Reagents from Sanquin Health Solutions (SHS) as the first investment from its €517m private equity fund (GHPE IV) that closed in…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


